Neurimmune Therapeutics AG

Neurimmune Therapeutics AG is an emerging biotechnology company dedicated to the identification of novel therapeutics for the treatment of human diseases with a focus on neurodegenerative disorders such as Alzheimer’s disease.

Based on its unique technology platform RTM™ (Reverse Translational Medicine) Neurimmune’s lead programs focus on the development of proprietary human antibodies as therapeutics and are currently in preclinical development. Neurimmune’s approach to antibody drug discovery provides a number of unique advantages that result in a superior risk profile compared to traditional antibody drug discovery approaches substantially increasing the speed to IND and clinical proof of concept.

Contact Details: Wagistrasse 13 Schlieren CH-8952 Switzerland Tel: +41 44 755 46 46 Fax: +41 44 755 46 47 Email: info@neurimmune.com WWW: /www.neurimmune.com/

BioNews Results for Neurimmune Therapeutics AG:
Neurimmune Therapeutics Announces Advancement of AlzheimerEURs Program into Preclinical Development	Pharma Live:  Aug 19 2009 1:30PM Matching: neurimmune therapeutics ag
Neurimmune Therapeutics Advances Alzheimer Program into Preclinical Development	BioPortfolio:  Aug 18 2009 3:26PM Matching: neurimmune therapeutics ag

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 46 times since April 2007, the link to the organisation's website has been followed 10 times

Search for more companies in Schlieren

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Neurimmune Therapeutics AG